Bills Search Results

Search all bills

Keyword(s)
Status
Current Bills
Previous Bills
Type

TOTAL RESULTS: 394

  • Date
    31 Aug 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register Bill 2016, the bill amends the:
    Australian Immunisation Register Act 2015
    to authorise the disclosure of specified information kept on the Australian Immunisation Register to the National Cancer Screening Register;
    Freedom of Information Act 1982
    to exempt register information from disclosure in response to a freedom of information request; and
    Health Insurance Act 1973
    to enable the ongoing provision of Medicare enrolment and claims data to the register. 

    Bill | Explanatory Memorandum

  • Date
    31 Aug 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016, the bill: establishes the National Cancer Screening Register, a national electronic infrastructure for the collection, storage, analysis and reporting of cancer screen program data for the National Cervical Screening Program and the National Bowel Cancer Screening Program; authorises the collection, use and disclosure of information for the purposes of the register; creates an offence for the unauthorised disclosure of information; and mandates reporting of screening information to the register. 

    Bill | Explanatory Memorandum

  • Date
    05 May 2016 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register Bill 2016, the bill amends the
    Australian Immunisation Register Act 2015
    ,
    Australian Institute of Health and Welfare Act 1987
    and
    Health Insurance Act 1973
    to authorise the disclosure of specified information for inclusion in the National Cancer Screening Register. Also authorises the transfer of state and territory cervical screening data to the register. 

    Bill | Explanatory Memorandum

  • Date
    05 May 2016 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Introduced with the National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016, the bill: establishes the National Cancer Screening Register, a national electronic infrastructure for the collection, storage, analysis and reporting of cancer screen program data for the National Cervical Screening Program and the National Bowel Cancer Screening Program; authorises the collection, use and disclosure of information for the purposes of the register; creates an offence for the unauthorised disclosure of information; and mandates reporting of screening information to the register. 

    Bill | Explanatory Memorandum

  • Date
    10 Feb 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    Narcotic Drugs Act 1967
    to: give effect to certain of Australia’s obligations under the Single Convention on Narcotic Drugs, 1961 (the Single Convention); establish licensing and permit schemes for the cultivation and production of cannabis and cannabis resin for medicinal and scientific purposes, and for the manufacture of narcotic drugs covered by the Single Convention; provide for monitoring, inspection and enforcement powers for authorised inspectors and for the secretary to give directions to licence holders and former licence holders; and enable the secretary to authorise a state or territory government agency to undertake cultivation and production of cannabis and manufacture of medicinal cannabis products; and the
    Therapeutic Goods Act 1989
    to make a consequential amendment. 

    Bill | Explanatory Memorandum

  • Date
    27 May 2015 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to implement the Pharmaceutical Benefits Scheme (PBS) Access and Sustainability package by: applying a one-off five per cent statutory price reduction for single brand medicines; changing price disclosure arrangements for multiple-brand medicines; applying flow-on price disclosure reductions from component drugs to multiple-brand combination medicines; changing membership arrangements for the Pharmaceutical Benefits Advisory Committee; enabling approved pharmacists to discount patient co-payments by a maximum of $1 for each PBS supply on a prescription; extending safety net early supply rules; and extending the pharmacy location rules and the role of the Australian Community Pharmacy Authority to 30 June 2020. Also makes technical amendments. 

    Bill | Explanatory Memorandum

  • Date
    18 Jun 2014 
    Chamber
    House of Representatives 
    Status
    Not Proceeding 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    in relation to the Pharmaceutical Benefits Scheme and the Repatriation Pharmaceutical Benefits Scheme by: increasing the concessional patient co-payment by 80 cents from 1 January 2015; increasing the general patient co-payment by $5.00 from 1 January 2015; increasing the concessional safety net threshold by two prescriptions each year for four years, from 2015 to 2018; and increasing the general patient safety net threshold by 10 per cent each year for four years, from 2015 to 2018. 

    Bill | Explanatory Memorandum

  • Date
    21 Nov 2013 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Implements the simplified price disclosure measure by amending the
    National Health Act 1953
    to: provide that 1 April or 1 October are price disclosure reduction days; and ensure that the existing Pharmaceutical Benefits Scheme (PBS) price for a medicine is not reduced by a price disclosure reduction unless the weighted average market price is at least 10 per cent less than the PBS price on the day the 10 per cent test is applied. 

    Bill | Explanatory Memorandum

  • Date
    21 Aug 2024 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Aged Care 
    Summary
    Amends the
    National Health Act 1953
    to clarify the operation of provisions relating to pricing and supply arrangements for older and low-cost medicines that are more susceptible to medicine shortages. 

    Bill | Explanatory Memorandum

  • Date
    06 Jun 2024 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Aged Care 
    Summary
    Amends the
    National Health Act 1953
    to: introduce an additional community supply support payment for eligible supplies of pharmaceutical benefits made by approved pharmacists; freeze indexation of the general patient co-payment for 1 year and indexation of the concessional co-payments for 5 years; phase-out the $1 allowable discount that pharmacies can choose to offer to patients; and make minor technical amendments. 

    Bill | Explanatory Memorandum